Loading clinical trials...
Loading clinical trials...
Prophylactic Salpingectomy With Delayed Oophorectomy, Risk-Reducing Salpingo-Oophorectomy, and Ovarian Cancer Screening Among BRCA Mutation Carriers: A Proof-of-Concept Study
Conditions
Interventions
Ovarian Cancer Screening
Prophylactic Salpingectomy with Delayed Oophorectomy
+4 more
Locations
2
United States
NorthShore University Health System
Evanston, Illinois, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
August 26, 2013
Primary Completion Date
December 31, 2030
Completion Date
December 31, 2030
Last Updated
October 27, 2025
NCT04550494
NCT06799065
NCT04851119
NCT07144826
NCT06290193
NCT04686682
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions